NCT07127627

Brief Summary

The aim of the study is to identify and characterize lesions in the abdominopelvic region detected by 18fluorine- fluorodeoxyglucose (FDG) positron Emission Tomography combined Computed Tomography (PET/CT) scan, including determining their malignant or benign nature, and to determine the extent of disease to facilitate proper management

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
79

participants targeted

Target at P50-P75 for all trials

Timeline
31mo left

Started Aug 2025

Typical duration for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress24%
Aug 2025Nov 2028

Study Start

First participant enrolled

August 1, 2025

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

August 9, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

August 17, 2025

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2028

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2028

Last Updated

August 17, 2025

Status Verified

August 1, 2025

Enrollment Period

3.2 years

First QC Date

August 9, 2025

Last Update Submit

August 14, 2025

Conditions

Abdominal Sepsis

Keywords

abdominopelvic lesions

Outcome Measures

Primary Outcomes (1)

  • Evaluate the performance of 18F FDG PET/CT

    identify and characterize abdominopelvic lesions, initial staging, follow up of treatment and detection of recurrence in the abdominopelvic region, including determining their malignant or benign nature, and to determine the extent of disease, Assess the spread of disease to lymph nodes, distant metastases, or other areas, to facilitate proper management.

    3 years

Secondary Outcomes (1)

  • Evaluate the diagnostic power of alternative technologies

    3 years

Interventions

PET/CTDEVICE

positron emission tomography/computed tomography

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

patients were suspected of having malignancy (new, recurrent or metastatic) based on pathology or conventional radiological studies and were referred to nuclear medicine unit for 18F-FDG-PET-CT scan

You may not qualify if:

  • patients underwent recent abdominal or pelvic surgery.
  • patients with blood glucose level ˃200 mg/dL
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (5)

  • Bouchelouche K. PET/CT in Bladder Cancer: An Update. Semin Nucl Med. 2022 Jul;52(4):475-485. doi: 10.1053/j.semnuclmed.2021.12.004. Epub 2022 Jan 5.

    PMID: 34996595BACKGROUND

  • Khandelwal Y, Singh Parihar A, Sistani G, Ramirez-Fort MK, Zukotynski K, Subramaniam RM. Role of PET/Computed Tomography in Gastric and Colorectal Malignancies. PET Clin. 2024 Apr;19(2):177-186. doi: 10.1016/j.cpet.2023.12.004. Epub 2024 Jan 9.

    PMID: 38199915BACKGROUND

  • Wang J, Liu X. Medical image recognition and segmentation of pathological slices of gastric cancer based on Deeplab v3+ neural network. Comput Methods Programs Biomed. 2021 Aug;207:106210. doi: 10.1016/j.cmpb.2021.106210. Epub 2021 May 29.

    PMID: 34130088BACKGROUND

  • Sartin SL, Shetty DR, Strange CD, Gayer G, Ahuja J, Agrawal R, Truong MT. Pitfalls in Positron Emission Tomography/Computed Tomography in the Thorax and Abdomen. Semin Ultrasound CT MR. 2024 Dec;45(6):488-495. doi: 10.1053/j.sult.2024.07.012. Epub 2024 Jul 26.

    PMID: 39069275BACKGROUND

  • Cao Y, Zhou K, Diao W, Long X, Tian F, Su M, Jia Z. Age-related changes of standardized uptake values in the blood pool and liver: a decade-long retrospective study of the outcomes of 2,526 subjects. Quant Imaging Med Surg. 2021 Jan;11(1):95-106. doi: 10.21037/qims-20-35.

    PMID: 33392014BACKGROUND

MeSH Terms

Conditions

Intraabdominal Infections

Interventions

Positron Emission Tomography Computed Tomography

Condition Hierarchy (Ancestors)

Infections

Intervention Hierarchy (Ancestors)

Positron-Emission TomographyTomography, Emission-ComputedImage Interpretation, Computer-AssistedDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisTomography, X-Ray ComputedMultimodal ImagingRadiographic Image EnhancementImage EnhancementPhotographyRadiographyTomography, X-RayRadionuclide ImagingTomographyDiagnostic Techniques, Radioisotope

Central Study Contacts

salma A samy, ass. lecturer

CONTACT

01069720261salmasamy95@aun.edu.eg

waleed A diab, ass. prof

CONTACT

01004242213Waleed.diab@aun.edu.eg

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
assistant lecturer of nuclear medicine

Study Record Dates

First Submitted

August 9, 2025

First Posted

August 17, 2025

Study Start

August 1, 2025

Primary Completion (Estimated)

October 1, 2028

Study Completion (Estimated)

November 1, 2028

Last Updated

August 17, 2025

Record last verified: 2025-08